$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000139681416000028 Filed on November 02, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q3
Revenue	$72.90M	$68.36M	$62.21M
YoY Change	5.17%	9.87%	19.53%
Cost Of Revenue	$23.62M	$43.15M	$15.90M
YoY Change	21.59%	171.38%	-22.02%
Gross Profit	$49.28M	$25.20M	$46.31M
YoY Change	-1.23%	-45.58%	46.29%
Gross Profit Margin	67.6%	36.87%	74.44%
Selling, General & Admin	$34.70M	$36.31M	$35.31M
YoY Change	-7.71%	2.84%	25.14%
% of Gross Profit	70.41%	144.09%	76.24%
Research & Development	$17.10M	$9.754M	$5.893M
YoY Change	29.55%	65.52%	33.18%
% of Gross Profit	34.7%	38.7%	12.72%
Depreciation & Amortization	$3.260M	$3.300M	$2.800M
YoY Change	4.49%	17.86%	21.74%
% of Gross Profit	6.62%	13.09%	6.05%
Operating Expenses	$75.36M	$89.22M	$57.10M
YoY Change	7.46%	56.24%	7.68%
Operating Profit	-$26.08M	-$20.87M	$5.109M
YoY Change	28.86%	-508.4%	-618.68%
Interest Expense	-$1.500M	$1.601M	$1.905M
YoY Change	-11.76%	-15.96%	-6.48%
% of Operating Profit			37.29%
Other Income/Expense, Net	-$100.0K	-$1.263M	-$1.742M
YoY Change	0.0%	-27.5%	-13.72%
Pretax Income	-$4.000M	-$22.13M	$3.367M
YoY Change	53.85%	-757.2%	-212.08%
Income Tax	$0.00	$36.00K	$281.0K
% Of Pretax Income			8.35%
Net Earnings	-$3.973M	-$22.16M	$3.086M
YoY Change	59.05%	-818.21%	-202.73%
Net Earnings / Revenue	-5.45%	-32.42%	4.96%
Basic Earnings Per Share		-$0.59	$0.08
Diluted Earnings Per Share	-$107.0K	-$0.59	$0.08
COMMON SHARES
Basic Shares Outstanding	37.40M shares	37.31M shares	36.66M shares
Diluted Shares Outstanding		37.31M shares	41.04M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$172.6M	$161.1M	$146.4M
YoY Change	8.55%	10.04%	-2.2%
Cash & Equivalents	$35.94M	$24.44M	$30.52M
Short-Term Investments	$136.7M	$136.7M	$115.9M
Other Short-Term Assets	$9.300M	$10.10M	$4.600M
YoY Change	52.46%	119.57%	-13.21%
Inventory	$31.28M	$37.48M	$56.13M
Prepaid Expenses
Receivables	$29.94M	$26.77M	$25.92M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$243.1M	$235.4M	$233.1M
YoY Change	-3.76%	1.01%	16.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$101.0M	$100.4M	$86.32M
YoY Change	11.84%	16.29%	53.74%
Goodwill	$46.74M	$44.67M	$28.89M
YoY Change	51.35%	54.63%	31.02%
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$17.90M
YoY Change	-100.0%	-100.0%	-26.94%
Other Assets	$624.0K	$651.0K	$2.595M
YoY Change	53.69%	-74.91%	-11.97%
Total Long-Term Assets	$148.4M	$145.7M	$135.9M
YoY Change	9.78%	7.23%	28.01%
TOTAL ASSETS
Total Short-Term Assets	$243.1M	$235.4M	$233.1M
Total Long-Term Assets	$148.4M	$145.7M	$135.9M
Total Assets	$391.5M	$381.2M	$369.0M
YoY Change	0.96%	3.3%	20.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.511M	$7.287M	$8.471M
YoY Change	-14.05%	-13.98%	9.35%
Accrued Expenses	$36.67M	$31.08M	$30.30M
YoY Change	3.65%	2.58%	29.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$107.6M	$104.9M
YoY Change	-100.0%	2.57%	2.74%
Long-Term Debt Due	$118.5M		$0.00
YoY Change	0.0%		-100.0%
Total Short-Term Liabilities	$44.84M	$146.8M	$145.4M
YoY Change	-70.07%	0.98%	7.53%
LONG-TERM LIABILITIES
Long-Term Debt	$108.7M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$18.91M	$12.56M	$6.125M
YoY Change	64.86%	105.01%	17.0%
Total Long-Term Liabilities	$18.91M	$12.56M	$6.125M
YoY Change	64.86%	105.01%	17.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.84M	$146.8M	$145.4M
Total Long-Term Liabilities	$18.91M	$12.56M	$6.125M
Total Liabilities	$172.5M	$167.0M	$160.0M
YoY Change	1.86%	4.39%	6.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$346.2M	-$342.3M	-$305.8M
YoY Change	12.31%	11.93%	-3.21%
Common Stock	$37.00K	$37.00K	$37.00K
YoY Change	0.0%	0.0%	2.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$219.0M	$214.1M	$209.0M
YoY Change
Total Liabilities & Shareholders Equity	$391.5M	$381.2M	$369.0M
YoY Change	0.96%	3.3%	20.82%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q3
OPERATING ACTIVITIES
Net Income	-$3.973M	-$22.16M	$3.086M
YoY Change	59.05%	-818.21%	-202.73%
Depreciation, Depletion And Amortization	$3.260M	$3.300M	$2.800M
YoY Change	4.49%	17.86%	21.74%
Cash From Operating Activities	$17.35M	$11.68M	$2.820M
YoY Change	8.03%	314.18%	-68.6%
INVESTING ACTIVITIES
Capital Expenditures	-$4.880M	-$3.910M	-$9.610M
YoY Change	-40.12%	-59.31%	94.14%
Acquisitions
YoY Change
Other Investing Activities	-$2.040M	-$9.410M	$2.760M
YoY Change	-112.45%	-440.94%	-102.85%
Cash From Investing Activities	-$6.910M	-$13.32M	-$6.840M
YoY Change	-183.96%	94.74%	-93.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.070M	770.0K	1.830M
YoY Change	-50.69%	-57.92%	-23.11%
NET CHANGE
Cash From Operating Activities	17.35M	11.68M	2.820M
Cash From Investing Activities	-6.910M	-13.32M	-6.840M
Cash From Financing Activities	1.070M	770.0K	1.830M
Net Change In Cash	11.51M	-870.0K	-2.190M
YoY Change	-56.5%	-60.27%	-97.58%
FREE CASH FLOW
Cash From Operating Activities	$17.35M	$11.68M	$2.820M
Capital Expenditures	-$4.880M	-$3.910M	-$9.610M
Free Cash Flow	$22.23M	$15.59M	$12.43M
YoY Change	-8.18%	25.42%	-10.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37402282	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	361000	USD
	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	359000	USD
	pcrx	Collaborative Agreement Fee Payment Period CollaborativeAgreementFeePaymentPeriod	P2Y
CY2013Q4	pcrx	Collaborative Arrangement Agreement Term CollaborativeArrangementAgreementTerm	P5Y
CY2015Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	357000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1069000	USD
CY2016Q3	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1357000	USD
	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3069000	USD
CY2015Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	176000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	629000	USD
CY2016Q3	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	102000	USD
	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	676000	USD
CY2015Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6991000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	19926000	USD
CY2016Q3	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5684000	USD
	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	18318000	USD
CY2015Q3	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	402000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	1459000	USD
CY2016Q3	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	150000	USD
	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	872000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2016Q3	pcrx	Contract Termination Fee ContractTerminationFee	7100000	USD
CY2016Q3	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	4700000	USD
CY2016Q3	pcrx	Contract Termination Fee Long Term Portion ContractTerminationFeeLongTermPortion	2400000	USD
CY2015Q3	pcrx	Conversion Request Convertible Senior Notes ConversionRequestConvertibleSeniorNotes	1500000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	1466000	USD
	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	4000	USD
CY2016Q3	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	1300000	shares
CY2016Q3	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	44900000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	3930000	USD
	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2015Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	25900000	USD
CY2016Q3	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	32300000	USD
	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	5790000	USD
	pcrx	Goodwill Recordedon Milestone Payments GoodwillRecordedonMilestonePayments	8000000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	276000	USD
	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	0	USD
CY2015Q3	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	3367000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	4726000	USD
CY2016Q3	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-22128000	USD
	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-33851000	USD
CY2015Q3	pcrx	Income Tax Provision IncomeTaxProvision	300000	USD
	pcrx	Income Tax Provision IncomeTaxProvision	400000	USD
CY2016Q3	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2015Q3	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	3000	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	1000	shares
CY2016Q3	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2015	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	5127000	USD
	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	13790000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	1195000	USD
	pcrx	Proceedsfrom Shares Issued Under Employee Stock Purchase Plans ProceedsfromSharesIssuedUnderEmployeeStockPurchasePlans	995000	USD
CY2015Q3	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2016Q3	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	20700000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8739000	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	7287000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25855000	USD
CY2016Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26765000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35375000	USD
CY2016Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31077000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24917000	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34488000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-52000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-28000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	526696000	USD
CY2016Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	556405000	USD
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-2000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23516000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8826000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23640000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7361000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23516000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3080000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3066000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2454000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1838000	shares
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6774000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6979000	shares
CY2015Q4	us-gaap	Assets Assets	387735000	USD
CY2016Q3	us-gaap	Assets Assets	381153000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	252582000	USD
CY2016Q3	us-gaap	Assets Current AssetsCurrent	235444000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	115495000	USD
CY2016Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	136714000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	33000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	18000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85000	USD
CY2016Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	46000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2595000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	185000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37520000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30522000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24442000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36848319	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37273407	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36848319	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37273407	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3084000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4405000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22330000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-33953000	USD
CY2015Q4	us-gaap	Convertible Debt ConvertibleDebt	118533000	USD
CY2016Q3	us-gaap	Convertible Debt ConvertibleDebt	118531000	USD
CY2015Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	104040000	USD
CY2016Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	107563000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	15901000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	52409000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	43152000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	86483000	USD
CY2016Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1300000	shares
CY2016Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days DebtInstrumentConvertibleThresholdConsecutiveTradingDays	P30D
CY2016Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
CY2016Q3	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12605000	USD
CY2016Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9539000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1888000	USD
CY2016Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1429000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2016Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	822000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8082000	USD
CY2016Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	7617000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	2800000	USD
	us-gaap	Depreciation Depreciation	8100000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	3300000	USD
	us-gaap	Depreciation Depreciation	9600000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8356000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9659000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14919000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	81000	USD
CY2016Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	USD
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-51000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-100000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	30880000	USD
CY2016Q3	us-gaap	Goodwill Goodwill	44670000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3776000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6014000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-21780000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-32806000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3367000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4726000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22128000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-33851000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-409000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1288000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-348000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1045000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	281000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	372000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	126000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	199000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	253000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1100000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5691000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3553000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	910000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1069000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1069000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26869000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24169000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	990000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1184000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	647000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4202000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1509000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2841000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3256000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1530000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1698000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	600000	USD
CY2016Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	500000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1200000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	1905000	USD
	us-gaap	Interest Expense InterestExpense	5842000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	1601000	USD
	us-gaap	Interest Expense InterestExpense	5203000	USD
	us-gaap	Interest Paid InterestPaid	4224000	USD
	us-gaap	Interest Paid InterestPaid	3852000	USD
CY2016Q3	us-gaap	Inventory Adjustments InventoryAdjustments	1200000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32781000	USD
CY2016Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12744000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	61645000	USD
CY2016Q3	us-gaap	Inventory Net InventoryNet	37476000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16712000	USD
CY2016Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	13291000	USD
CY2016Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	20700000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12152000	USD
CY2016Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11441000	USD
CY2016Q3	us-gaap	Inventory Write Down InventoryWriteDown	21300000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	21900000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	171000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	504000	USD
CY2016Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	346000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	923000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	169343000	USD
CY2016Q3	us-gaap	Liabilities Liabilities	167005000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	387735000	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	381153000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	149788000	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	146831000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	104040000	USD
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	107563000	USD
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments	13462000	USD
CY2016Q3	us-gaap	Long Term Investments LongTermInvestments	0	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-6998000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-32542000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8527000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6191000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-26552000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-54837000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	11027000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16104000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	3086000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4354000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-22164000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-33977000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1742000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5542000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1263000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4288000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	57104000	USD
	us-gaap	Operating Expenses OperatingExpenses	169408000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	89220000	USD
	us-gaap	Operating Expenses OperatingExpenses	233032000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	5109000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	10268000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20865000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-29563000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	41358000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	6420000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8303000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8081000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7878000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8731000	USD
CY2016Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1945000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	406000	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	651000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	51000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-166000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	24000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	51000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-166000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	24000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11473000	USD
CY2016Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12557000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31212000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19827000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	125197000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	158390000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6117000	USD
CY2016Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10075000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	134984000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	137170000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8798000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5200000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	115241000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	134876000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90324000	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	100388000	USD
	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	300000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5893000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15509000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9754000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28609000	USD
CY2015Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	1257000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1626000	USD
CY2016Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	1425000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	3650000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308289000	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-342266000	USD
CY2015Q3	us-gaap	Revenues Revenues	62213000	USD
	us-gaap	Revenues Revenues	179676000	USD
CY2016Q3	us-gaap	Revenues Revenues	68355000	USD
	us-gaap	Revenues Revenues	203469000	USD
CY2015Q3	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	71000	USD
CY2016Q3	us-gaap	Royalty Expense RoyaltyExpense	0	USD
	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2015Q3	us-gaap	Royalty Revenue RoyaltyRevenue	706000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	2310000	USD
CY2016Q3	us-gaap	Royalty Revenue RoyaltyRevenue	879000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	2091000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	61150000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	176297000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	66119000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	198309000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35310000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	101490000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	36314000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	117940000	USD
CY2015Q3	us-gaap	Share Based Compensation ShareBasedCompensation	8826000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23640000	USD
CY2016Q3	us-gaap	Share Based Compensation ShareBasedCompensation	7361000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	23516000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	4000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	38.94
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.72
CY2016Q3	us-gaap	Share Price SharePrice	34.22
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	101981000	USD
CY2016Q3	us-gaap	Short Term Investments ShortTermInvestments	136686000	USD
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	35000	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	34705	shares
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	995000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5200000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	218392000	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	214148000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	208000	USD
CY2016Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	82000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2016Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41043000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41422000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37312000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37171000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36663000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36460000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37312000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37171000	shares

Files In Submission

Name	View Source	Status
0001396814-16-000028-index-headers.html	Edgar Link	pending
0001396814-16-000028-index.html	Edgar Link	pending
0001396814-16-000028.txt	Edgar Link	pending
0001396814-16-000028-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pcrx-20160930.xml	Edgar Link	completed
pcrx-20160930.xsd	Edgar Link	pending
pcrx-20160930_cal.xml	Edgar Link	unprocessable
pcrx-20160930_def.xml	Edgar Link	unprocessable
pcrx-20160930_lab.xml	Edgar Link	unprocessable
pcrx-20160930_pre.xml	Edgar Link	unprocessable
pcrx-93016xex311.htm	Edgar Link	pending
pcrx-93016xex312.htm	Edgar Link	pending
pcrx-93016xex321.htm	Edgar Link	pending
pcrx-93016xex322.htm	Edgar Link	pending
pcrx-9302016x10xq.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2016 Q4 Form 10-Q Financial Statement

#000139681416000028 Filed on November 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2016 Q4 Form 10-Q Financial Statement

#000139681416000028 Filed on November 02, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx